758 related articles for article (PubMed ID: 25074507)
21. Impact of nesiritide on renal function and mortality in patients suffering from heart failure.
Dontas ID; Xanthos T; Dontas I; Lelovas P; Papadimitriou L
Cardiovasc Drugs Ther; 2009 Jun; 23(3):221-33. PubMed ID: 19252976
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure.
Tang WH; Wu Y; Grodin JL; Hsu AP; Hernandez AF; Butler J; Metra M; Voors AA; Felker GM; Troughton RW; Mills RM; McMurray JJ; Armstrong PW; O'Connor CM; Starling RC
JACC Heart Fail; 2016 Jan; 4(1):68-77. PubMed ID: 26656144
[TBL] [Abstract][Full Text] [Related]
23. Worsening renal function in children hospitalized with decompensated heart failure: evidence for a pediatric cardiorenal syndrome?
Price JF; Mott AR; Dickerson HA; Jefferies JL; Nelson DP; Chang AC; O'Brian Smith E; Towbin JA; Dreyer WJ; Denfield SW; Goldstein SL
Pediatr Crit Care Med; 2008 May; 9(3):279-84. PubMed ID: 18446113
[TBL] [Abstract][Full Text] [Related]
24. Effect of nesiritide on length of hospital stay in patients with decompensated heart failure.
Chang R; Elatre WA; Heywood JT
J Cardiovasc Pharmacol Ther; 2004 Sep; 9(3):173-7. PubMed ID: 15378137
[TBL] [Abstract][Full Text] [Related]
25. Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure.
Aronson D; Burger AJ
Am Heart J; 2004 Nov; 148(5):e16. PubMed ID: 15523294
[TBL] [Abstract][Full Text] [Related]
26. Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From the ASCEND-HF Trial.
Ambrosy AP; Cerbin LP; Armstrong PW; Butler J; Coles A; DeVore AD; Dunlap ME; Ezekowitz JA; Felker GM; Fudim M; Greene SJ; Hernandez AF; O'Connor CM; Schulte P; Starling RC; Teerlink JR; Voors AA; Mentz RJ
JACC Heart Fail; 2017 Jan; 5(1):1-13. PubMed ID: 28034373
[TBL] [Abstract][Full Text] [Related]
27. Worsening heart failure during hospitalization for acute heart failure: Insights from the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF).
Kelly JP; Mentz RJ; Hasselblad V; Ezekowitz JA; Armstrong PW; Zannad F; Felker GM; Califf RM; O'Connor CM; Hernandez AF
Am Heart J; 2015 Aug; 170(2):298-305. PubMed ID: 26299227
[TBL] [Abstract][Full Text] [Related]
28. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
[TBL] [Abstract][Full Text] [Related]
29. Effect of nesiritide in isolated right ventricular failure secondary to pulmonary hypertension.
Kelesidis I; Mazurek JA; Saeed W; Chaudhari R; Velankar P; Zolty R
Congest Heart Fail; 2012; 18(1):18-24. PubMed ID: 22277173
[TBL] [Abstract][Full Text] [Related]
30. Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction a randomized, double-blind, placebo-controlled clinical trial.
Witteles RM; Kao D; Christopherson D; Matsuda K; Vagelos RH; Schreiber D; Fowler MB
J Am Coll Cardiol; 2007 Nov; 50(19):1835-40. PubMed ID: 17980248
[TBL] [Abstract][Full Text] [Related]
31. Hypotension during hospitalization for acute heart failure is independently associated with 30-day mortality: findings from ASCEND-HF.
Patel PA; Heizer G; O'Connor CM; Schulte PJ; Dickstein K; Ezekowitz JA; Armstrong PW; Hasselblad V; Mills RM; McMurray JJ; Starling RC; Tang WH; Califf RM; Hernandez AF
Circ Heart Fail; 2014 Nov; 7(6):918-25. PubMed ID: 25281655
[TBL] [Abstract][Full Text] [Related]
32. A prospective evaluation of nesiritide in the treatment of pediatric heart failure.
Jefferies JL; Denfield SW; Price JF; Dreyer WJ; McMahon CJ; Grenier MA; Kim JJ; Dimas VV; Clunie SK; Moffett BS; Chang AC; Wann TI; Smith EO; Towbin JA
Pediatr Cardiol; 2006; 27(4):402-7. PubMed ID: 16830089
[TBL] [Abstract][Full Text] [Related]
33. Global variation in quality of care among patients hospitalized with acute heart failure in an international trial: findings from the acute study clinical effectiveness of nesiritide in decompensated heart failure trial (ASCEND-HF).
Howlett JG; Ezekowitz JA; Podder M; Hernandez AF; Diaz R; Dickstein K; Dunlap ME; Corbalán R; Armstrong PW; Starling RC; O'Connor CM; Califf RM; Fonarow GC;
Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):534-42. PubMed ID: 23899930
[TBL] [Abstract][Full Text] [Related]
34. Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
Greene SJ; Hernandez AF; Sun JL; Metra M; Butler J; Ambrosy AP; Ezekowitz JA; Starling RC; Teerlink JR; Schulte PJ; Voors AA; Armstrong PW; O'Connor CM; Mentz RJ
Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623769
[TBL] [Abstract][Full Text] [Related]
35. Observation unit treatment of heart failure with nesiritide: results from the proaction trial.
Peacock WF; Holland R; Gyarmathy R; Dunbar L; Klapholz M; Horton DP; de Lissovoy G; Emerman CL
J Emerg Med; 2005 Oct; 29(3):243-52. PubMed ID: 16183441
[TBL] [Abstract][Full Text] [Related]
36. Prophylactic nesiritide does not prevent dialysis or all-cause mortality in patients undergoing high-risk cardiac surgery.
Ejaz AA; Martin TD; Johnson RJ; Winterstein AG; Klodell CT; Hess PJ; Ali AK; Whidden EM; Staples NL; Alexander JA; House-Fancher MA; Beaver TM
J Thorac Cardiovasc Surg; 2009 Oct; 138(4):959-64. PubMed ID: 19660420
[TBL] [Abstract][Full Text] [Related]
37. Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models.
Khazanie P; Heizer GM; Hasselblad V; Armstrong PW; Califf RM; Ezekowitz J; Dickstein K; Levy WC; McMurray JJ; Metra M; Tang WH; Teerlink JR; Voors AA; O'Connor CM; Hernandez AF; Starling R
Am Heart J; 2015 Aug; 170(2):290-7. PubMed ID: 26299226
[TBL] [Abstract][Full Text] [Related]
38. Worsening of renal function during 1 year after hospital discharge is a strong and independent predictor of all-cause mortality in acute decompensated heart failure.
Ueda T; Kawakami R; Sugawara Y; Okada S; Nishida T; Onoue K; Soeda T; Okayama S; Takeda Y; Watanabe M; Kawata H; Uemura S; Saito Y
J Am Heart Assoc; 2014 Nov; 3(6):e001174. PubMed ID: 25370599
[TBL] [Abstract][Full Text] [Related]
39. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure.
Sackner-Bernstein JD; Skopicki HA; Aaronson KD
Circulation; 2005 Mar; 111(12):1487-91. PubMed ID: 15781736
[TBL] [Abstract][Full Text] [Related]
40. Renal function and neurohormonal changes following intravenous infusions of nitroglycerin versus nesiritide in patients with acute decompensated heart failure.
Chow SL; O'Barr SA; Peng J; Chew E; Pak F; Quist R; Patel P; Patterson JH; Heywood JT
J Card Fail; 2011 Mar; 17(3):181-7. PubMed ID: 21362524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
